References
- Gupta R, Woo K, Yi JA. Epidemiology of end-stage kidney disease. Semin Vasc Surg. 2021;34(1):71–78.
- Hou Y, Li L, Zhou Q, et al. Relationships between social Capital, patient empowerment, and self-management of patients undergoing hemodialysis: a cross-sectional study. BMC Nephrol. 2022;23(1):71.
- Wang F, Yang C, Long J, et al. Executive summary for the 2015 annual data report of the China kidney disease network (CK-NET). Kidney Int. 2019;95(3):501–505.
- Wu Y-L, Zhang J-J, Li R-J, et al. Prevalence of infections and antimicrobial use among hemodialysis outpatients: a prospective multicenter study. Semin Dial. 2020;33(2):156–162.
- Lamarca F, Carrero JJ, Rodrigues JCD, et al. Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria. J Nutr Health Aging. 2014;18(7):710–717. 101007/s12603-014-0505-5
- Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. The Lancet. 2020;395(10225):709–733.
- Shu X, Lin T, Wang H, et al. Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):145–158.
- Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.
- DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32 Suppl 2(Suppl 2):S157–S163.
- Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab. 2011;96(9):2898–2903.
- Leyking S, Fliser D. Insulin resistance in CKD. Clin J Am Soc Nephrol. 2014;9(4):638–640.
- Teta D. Insulin resistance as a therapeutic target for chronic kidney disease. J Ren Nutr. 2015;25(2):226–229.
- Pham H, Utzschneider KM, de Boer IH. Measurement of insulin resistance in chronic kidney disease. Curr Opin Nephrol Hypertens. 2011;20(6):640–646.
- Chamroonkiadtikun P, Ananchaisarp T, Wanichanon W. The triglyceride-glucose index, a predictor of type 2 diabetes development: a retrospective cohort study. Prim Care Diabetes. 2020;14(2):161–167.
- Wang L, Cong H-L, Zhang J-X, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80.
- Chen L-K, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307 e302.
- Kalantar-Zadeh K, Kopple JD, Block G, et al. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38(6):1251–1263.
- Karavetian M, Salhab N, Rizk R, et al. Malnutrition-inflammation score VS phase angle in the era of GLIM criteria: a cross-sectional study among hemodialysis patients in UAE. Nutrients. 2019;11(11):2771.
- Wang XH, Mitch WE, Price SR. Pathophysiological mechanisms leading to muscle loss in chronic kidney disease. Nat Rev Nephrol. 2022;18(3):138–152.
- Chatzipetrou V, Begin MJ, Hars M, et al. Sarcopenia in chronic kidney disease: a scoping review of prevalence, risk factors, association with outcomes, and treatment. Calcif Tissue Int. 2022;110(1):1–31.
- Avin KG, Moorthi RN. Bone is not alone: the effects of skeletal muscle dysfunction in chronic kidney disease. Curr Osteoporos Rep. 2015;13(3):173–179.
- Carrero JJ, Stenvinkel P, Cuppari L, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013;23(2):77–90.
- Moorthi RN, Avin KG. Clinical relevance of sarcopenia in chronic kidney disease. Curr Opin Nephrol Hypertens. 2017;26(3):219–228.
- Sabatino A, Cuppari L, Stenvinkel P, et al. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol. 2021;34(4):1347–1372.
- Ribeiro HS, Neri SGR, Oliveira JS, et al. Association between sarcopenia and clinical outcomes in chronic kidney disease patients: a systematic review and meta-analysis. Clin Nutr. 2022;41(5):1131–1140.
- Takemura K, Nishi H, Inagi R. Mitochondrial dysfunction in kidney disease and uremic sarcopenia. Front Physiol. 2020;11:565023.
- Fragoso A, Mendes F, Silva AP, et al. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease. J Diabet Complications. 2015;29(8):1098–1104.
- Siew ED, Pupim LB, Majchrzak KM, et al. Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int. 2007;71(2):146–152.
- Thomas SS, Dong Y, Zhang L, et al. Signal regulatory protein-alpha interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease. Kidney Int. 2013;84(2):308–316.
- Artunc F, Schleicher E, Weigert C, et al. The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol. 2016;12(12):721–737.
- Park B, Lee HS, Lee YJ. Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults: a 12-year longitudinal study of the Korean Genome and Epidemiology Study cohort. Transl Res. 2021;228:42–51.
- Du T, Yuan G, Zhang M, et al. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13:146.
- Ahn SH, Lee JH, Lee JW. Inverse association between triglyceride glucose index and muscle mass in Korean adults: 2008–2011 KNHANES. Lipids Health Dis. 2020;19(1):243.
- Sabatino A, Regolisti G, Karupaiah T, et al. Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis. Clin Nutr. 2017;36(3):663–671.
- Kaysen GA. Progressive inflammation and wasting in patients with ESRD. Clin J Am Soc Nephrol. 2014;9(2):225–226.
- Sedhain A, Hada R, Agrawal RK, et al. Assessment of nutritional status of Nepalese hemodialysis patients by anthropometric examinations and modified quantitative subjective global assessment. Nutr Metab Insights. 2015;8:21–27.
- Hou Y, Li X, Hong D, et al. Comparison of different assessments for evaluating malnutrition in Chinese patients with end-stage renal disease with maintenance hemodialysis. Nutr Res. 2012;32(4):266–271.
- Gencer F, Yildiran H, Erten Y. Association of malnutrition inflammation score with anthropometric parameters, depression, and quality of life in hemodialysis patients. J Am Coll Nutr. 2019;38(5):457–462.
- Beberashvili I, Azar A, Sinuani I, et al. Comparison analysis of nutritional scores for serial monitoring of nutritional status in hemodialysis patients. CJASN. 2013;8(3):443–451.
- Segall L, Moscalu M, Hogaş S, et al. Protein-energy wasting, as well as overweight and obesity, is a long-term risk factor for mortality in chronic hemodialysis patients. Int Urol Nephrol. 2014;46(3):615–621.
- Ikizler TA, Cano NJ, Franch H, et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013;84(6):1096–1107.
- Bossola M, Muscaritoli M, Tazza L, et al. Malnutrition in hemodialysis patients: what therapy? Am J Kidney Dis. 2005;46(3):371–386.
- Ikizler TA. Optimal nutrition in hemodialysis patients. Adv Chronic Kidney Dis. 2013;20(2):181–189.
- Molfino A, Chiappini MG, Laviano A, et al. Effect of intensive nutritional counseling and support on clinical outcomes of hemodialysis patients. Nutrition. 2012;28(10):1012–1015.